Jazz Dives — And Takes Praxis With It — On Essential Tremor Drug FailureInvestors Business Daily • 06/20/24
Jazz Pharmaceuticals Provides Update on Phase 2b Trial of Investigational Suvecaltamide (JZP385) in Essential TremorPRNewsWire • 06/20/24
Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024PRNewsWire • 06/01/24
Jazz Pharmaceuticals Showcases Pioneering Research in Sleep Medicine at SLEEP 2024PRNewsWire • 05/30/24
Zanidatamab Granted Priority Review for HER2-Positive Metastatic Biliary Tract CancerPRNewsWire • 05/29/24
Jazz Pharmaceuticals Announces Collaboration with Life Science Cares to Improve the Wellbeing of Under Resourced Communities through Employee VolunteerismPRNewsWire • 05/22/24
The 7 Top-Selling Cannabis Companies Ranked by Revenue: Which Weed Stocks to Buy?InvestorPlace • 05/08/24
Jazz (JAZZ) Q1 Earnings: Taking a Look at Key Metrics Versus EstimatesZacks Investment Research • 05/02/24